Cancer Research Annual Meeting 2010 EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Girard, L.
Right arrow Articles by Minna, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Girard, L.
Right arrow Articles by Minna, J. D.
[Cancer Research 60, 4894-4906, September 1, 2000]
© 2000 American Association for Cancer Research

Molecular Biology and Genetics

Genome-wide Allelotyping of Lung Cancer Identifies New Regions of Allelic Loss, Differences between Small Cell Lung Cancer and Non-Small Cell Lung Cancer, and Loci Clustering1

Luc Girard, Sabine Zöchbauer-Müller, Arvind K. Virmani, Adi F. Gazdar and John D. Minna2

Hamon Center for Therapeutic Oncology Research [L. G., S. Z-M., A. K. V., A. F. G., J. D. M.] and Departments of Pathology [A. K. V., A. F. G.], Internal Medicine [J. D. M.], and Pharmacology [J. D. M.], University of Texas Southwestern Medical Center, Dallas, Texas 75390

To identify the major tumor suppressor gene (TSG) loci involved in the pathogenesis of lung cancer, we have conducted a high-resolution (10 cM), genome-wide search of loss of heterozygosity (LOH). Thirty-six lung cancer cell lines [14 small cell lung cancers (SCLCs) and 22 non-SCLCs (NSCLCs)] and their matched control DNAs were analyzed using 399 fluorescent microsatellite markers from the ABI Prism linkage mapping set v.2 on an ABI 377 sequencer/genotyper. Overall, 22 different regions with more than 60% LOH were identified: (a) 13 regions with a preference for SCLC; (b) 7 regions with a preference for NSCLC; and (c) 2 regions affecting both SCLC and NSCLC. The chromosomal arms with the most frequent LOH were 1p, 3p, 4p, 4q, 5q, 8p, 9p (p16), 9q, 10p, 10q, 13q (Rb), 15q, 17p (p53), 18q, 19p, Xp, Xq. In addition, new homozygous deletions were found at 2p23, 8q24, 18q11, and Xq22. On average, 34% (SCLC) to 36% (NSCLC) of markers showed allele loss in individual tumors, with an average size of subchromosomal region of loss of five to six markers (50–60 cM). Whereas SCLC and NSCLC had different regions of frequent LOH (hot spots), and NSCLC had more of these regions (n = 22) than SCLC (n = 17), in all other parameters (fractional allelic loss, number of breakpoints, and number of microsatellite alterations), SCLC and NSCLC were not significantly different. Clustering analysis revealed correlations between LOH on different chromosomes that suggest previously unknown genetic interactions for lung cancer development. We conclude that (a) in lung cancer cell lines, at least 17–22 chromosomal regions with frequent allele loss are involved, suggesting that the same number of putative TSGs are inactivated; (b) SCLC and NSCLC frequently undergo different specific genetic alterations; and (c) clusters of TSGs are likely to be inactivated together. Overall, these data provide global estimates of the extent of genetic changes leading to lung cancer and will be useful for the positional cloning of new TSGs and for the identification of multiple new biomarkers for translational research.




This article has been cited by other articles:


Home page
 Sci SignalHome page
H.-P. Kuo, D.-F. Lee, C.-T. Chen, M. Liu, C.-K. Chou, H.-J. Lee, Y. Du, X. Xie, Y. Wei, W. Xia, et al.
ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway
Sci. Signal., February 9, 2010; 3(108): ra9 - ra9.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J.-W. Jeong, H. S. Lee, K. Y. Lee, L. D. White, R. R. Broaddus, Y.-W. Zhang, G. F. Vande Woude, L. C. Giudice, S. L. Young, B. A. Lessey, et al.
Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease
PNAS, May 26, 2009; 106(21): 8677 - 8682.
[Abstract] [Full Text] [PDF]

Home page
 Am J Clin PatholHome page
P. L. Wagner, N. Kitabayashi, Y.-T. Chen, and A. Saqi
Combined Small Cell Lung Carcinomas: Genotypic and Immunophenotypic Analysis of the Separate Morphologic Components
Am J Clin Pathol, March 1, 2009; 131(3): 376 - 382.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Nakanishi, S. Matsumoto, R. Iwakawa, T. Kohno, K. Suzuki, K. Tsuta, Y. Matsuno, M. Noguchi, E. Shimizu, and J. Yokota
Whole Genome Comparison of Allelic Imbalance between Noninvasive and Invasive Small-Sized Lung Adenocarcinomas
Cancer Res., February 15, 2009; 69(4): 1615 - 1623.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Koschmieder, B. Halmos, E. Levantini, and D. G. Tenen
Dysregulation of the C/EBP{alpha} Differentiation Pathway in Human Cancer
J. Clin. Oncol., February 1, 2009; 27(4): 619 - 628.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Nymark, E. Kettunen, M. Aavikko, S. Ruosaari, E. Kuosma, E. Vanhala, K. Salmenkivi, R. Pirinen, A. Karjalainen, S. Knuutila, et al.
Molecular Alterations at 9q33.1 and Polyploidy in Asbestos-Related Lung Cancer
Clin. Cancer Res., January 15, 2009; 15(2): 468 - 475.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
P. H. Hartel, A. L. Shackelford, J. V. Hartel, and S. L. Wenger
Del(5q) Is Associated With Clinical and Histological Parameters in Small Cell Neuroendocrine Lung Carcinoma
International Journal of Surgical Pathology, October 1, 2008; 16(4): 419 - 423.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
G. Huang, R. Eisenberg, M. Yan, S. Monti, E. Lawrence, P. Fu, J. Walbroehl, E. Lowenberg, T. Golub, J. Merchan, et al.
15-Hydroxyprostaglandin Dehydrogenase is a Target of Hepatocyte Nuclear Factor 3{beta} and a Tumor Suppressor in Lung Cancer
Cancer Res., July 1, 2008; 68(13): 5040 - 5048.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. S. Pymar, F. M. Platt, J. M. Askham, E. E. Morrison, and M. A. Knowles
Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms
Hum. Mol. Genet., July 1, 2008; 17(13): 2006 - 2017.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Tessema, R. Willink, K. Do, Y. Y. Yu, W. Yu, E. O. Machida, M. Brock, L. Van Neste, C. A. Stidley, S. B. Baylin, et al.
Promoter Methylation of Genes in and around the Candidate Lung Cancer Susceptibility Locus 6q23-25
Cancer Res., March 15, 2008; 68(6): 1707 - 1714.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. Huang, Z. Hu, M. Li, Y. Cui, Y. Li, L. Guo, W. Jiang, and S. H. Lu
ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity
Carcinogenesis, November 1, 2007; 28(11): 2274 - 2281.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
R. Huijsmans, J. Damen, H. van der Linden, and M. Hermans
Single Nucleotide Polymorphism Profiling Assay to Confirm the Identity of Human Tissues
J. Mol. Diagn., April 1, 2007; 9(2): 205 - 213.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W.-G. Deng, H. Kawashima, G. Wu, G. Jayachandran, K. Xu, J. D. Minna, J. A. Roth, and L. Ji
Synergistic Tumor Suppression by Coexpression of FUS1 and p53 Is Associated with Down-regulation of Murine Double Minute-2 and Activation of the Apoptotic Protease-Activating Factor 1-Dependent Apoptotic Pathway in Human Non-Small Cell Lung Cancer Cells
Cancer Res., January 15, 2007; 67(2): 709 - 717.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. K. Thomas, B. Weir, and M. Meyerson
Genomic approaches to lung cancer.
Clin. Cancer Res., July 15, 2006; 12(14): 4384s - 4391s.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M.-F. Tsai, C.-C. Wang, G.-C. Chang, C.-Y. Chen, H.-Y. Chen, C.-L. Cheng, Y.-P. Yang, C.-Y. Wu, F.-Y. Shih, C.-C. Liu, et al.
A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
J Natl Cancer Inst, June 21, 2006; 98(12): 825 - 838.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Nymark, H. Wikman, S. Ruosaari, J. Hollmen, E. Vanhala, A. Karjalainen, S. Anttila, and S. Knuutila
Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
Cancer Res., June 1, 2006; 66(11): 5737 - 5743.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. Hata, K. Yoshimoto, N. Yokoyama, M. Mizoguchi, T. Shono, Y. Guan, T. Tahira, Y. Kukita, K. Higasa, S. Nagata, et al.
Allelic Losses of Chromosome 10 in Glioma Tissues Detected by Quantitative Single-Strand Conformation Polymorphism Analysis
Clin. Chem., March 1, 2006; 52(3): 370 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. T. Smith, M. Lin, R. M. Brena, J. C. Lang, D. E. Schuller, G. A. Otterson, C. D. Morrison, D. J. Smiraglia, and C. Plass
Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer
PNAS, January 24, 2006; 103(4): 982 - 987.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. H. Shin, S. M. Kang, Y. S. Kim, D. H. Shin, J. Chang, S. K. Kim, and S. K. Kim
Identification of Tumor Suppressor Loci on the Long Arm of Chromosome 5 in Pulmonary Large Cell Neuroendocrine Carcinoma
Chest, October 1, 2005; 128(4): 2999 - 3003.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. C. Hollander, R. T. Philburn, A. D. Patterson, S. Velasco-Miguel, E. C. Friedberg, R. I. Linnoila, and A. J. Fornace Jr.
Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis
PNAS, September 13, 2005; 102(37): 13200 - 13205.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Shibata, S. Uryu, A. Kokubu, F. Hosoda, M. Ohki, T. Sakiyama, Y. Matsuno, R. Tsuchiya, Y. Kanai, T. Kondo, et al.
Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features
Clin. Cancer Res., September 1, 2005; 11(17): 6177 - 6185.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
R. Meuwissen and A. Berns
Mouse models for human lung cancer
Genes & Dev., March 15, 2005; 19(6): 643 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Pan, J. Califano, J. F. Ponte, A. L. Russo, K.-h. Cheng, A. Thiagalingam, P. Nemani, D. Sidransky, and S. Thiagalingam
Loss of Heterozygosity Patterns Provide Fingerprints for Genetic Heterogeneity in Multistep Cancer Progression of Tobacco Smoke-Induced Non-Small Cell Lung Cancer
Cancer Res., March 1, 2005; 65(5): 1664 - 1669.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Garnis, J. Campbell, J. J. Davies, C. MacAulay, S. Lam, and W. L. Lam
Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis
Hum. Mol. Genet., February 15, 2005; 14(4): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Halmos, D. S. Basseres, S. Monti, F. D'Alo, T. Dayaram, K. Ferenczi, B. J. Wouters, C. S. Huettner, T. R. Golub, and D. G. Tenen
A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3{beta} as a Novel Tumor Suppressor in Lung Cancer
Cancer Res., June 15, 2004; 64(12): 4137 - 4147.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Ito, M. Uchiyama, M. Kondo, S. Mori, N. Usami, O. Maeda, T. Kawabe, Y. Hasegawa, K. Shimokata, and Y. Sekido
Kruppel-Like Factor 6 Is Frequently Down-Regulated and Induces Apoptosis in Non-Small Cell Lung Cancer Cells
Cancer Res., June 1, 2004; 64(11): 3838 - 3843.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y.-S. Jou, C.-S. Lee, Y.-H. Chang, C.-F. Hsiao, C.-F. Chen, C.-C. Chao, L. S.H. Wu, S.-H. Yeh, D.-S. Chen, and P.-J. Chen
Clustering of Minimal Deleted Regions Reveals Distinct Genetic Pathways of Human Hepatocellular Carcinoma
Cancer Res., May 1, 2004; 64(9): 3030 - 3036.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. A. Franklin
Premalignant Evolution of Lung Cancer: Gilles F. Filley Lecture
Chest, May 1, 2004; 125(5_suppl): 90S - 94S.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
C. A. Iacobuzio-Donahue, M. S. van der Heijden, M. R. Baumgartner, W. J. Troup, J. M. Romm, K. Doheny, E. Pugh, C. J. Yeo, M. G. Goggins, R. H. Hruban, et al.
Large-Scale Allelotype of Pancreaticobiliary Carcinoma Provides Quantitative Estimates of Genome-Wide Allelic Loss
Cancer Res., February 1, 2004; 64(3): 871 - 875.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
H. Kim, G.-L. Xu, A. C. Borczuk, S. Busch, J. Filmus, M. Capurro, J. S. Brody, J. Lange, J. M. D'Armiento, P. B. Rothman, et al.
The Heparan Sulfate Proteoglycan GPC3 Is a Potential Lung Tumor Suppressor
Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 694 - 701.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Natrajan, J. Louhelainen, S. Williams, J. Laye, and M. A. Knowles
High-Resolution Deletion Mapping of 15q13.2-q21.1 in Transitional Cell Carcinoma of the Bladder
Cancer Res., November 15, 2003; 63(22): 7657 - 7662.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
K M Fong, Y Sekido, A F Gazdar, and J D Minna
Lung cancer * 9: Molecular biology of lung cancer: clinical implications
Thorax, October 1, 2003; 58(10): 892 - 900.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. F. Paz, S. Wei, J. C. Cigudosa, S. Rodriguez-Perales, M. A. Peinado, T. H.-M. Huang, and M. Esteller
Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases
Hum. Mol. Genet., September 1, 2003; 12(17): 2209 - 2219.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Toyooka, K. O. Toyooka, K. Miyajima, J. L. Reddy, M. Toyota, U. G. Sathyanarayana, A. Padar, M. S. Tockman, S. Lam, N. Shivapurkar, et al.
Epigenetic Down-Regulation of Death-associated Protein Kinase in Lung Cancers
Clin. Cancer Res., August 1, 2003; 9(8): 3034 - 3041.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. Danesi, F. De Braud, S. Fogli, T. M. De Pas, A. Di Paolo, G. Curigliano, and M. Del Tacca
Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer
Pharmacol. Rev., March 1, 2003; 55(1): 57 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. N. Reisman, J. Sciarrotta, W. Wang, W. K. Funkhouser, and B. E. Weissman
Loss of BRG1/BRM in Human Lung Cancer Cell Lines and Primary Lung Cancers: Correlation with Poor Prognosis
Cancer Res., February 1, 2003; 63(3): 560 - 566.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
U. Novak, E. Oppliger Leibundgut, J. Hager, D. Muhlematter, M. Jotterand, C. Besse, N. Leupin, D. Ratschiller, J. Papp, G. Kearsey, et al.
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)
Blood, August 13, 2002; 100(5): 1787 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. P. Wong, W. K. Lam, E. Wang, S. W. Chiu, C. L. Lam, and L. P. Chung
Primary Adenocarcinomas of the Lung in Nonsmokers Show a Distinct Pattern of Allelic Imbalance
Cancer Res., August 1, 2002; 62(15): 4464 - 4468.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. O. Toyooka, S. Toyooka, A. Maitra, Q. Feng, N. C. Kiviat, A. Smith, J. D. Minna, R. Ashfaq, and A. F. Gazdar
Establishment and Validation of Real-Time Polymerase Chain Reaction Method for CDH1 Promoter Methylation
Am. J. Pathol., August 1, 2002; 161(2): 629 - 634.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Toyooka, Y. Fukuyama, I. I. Wistuba, M. S. Tockman, J. D. Minna, and A. F. Gazdar
Differential Expression of FEZ1/LZTS1 Gene in Lung Cancers and Their Cell Cultures
Clin. Cancer Res., July 1, 2002; 8(7): 2292 - 2297.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Miura, E. D. Bowman, R. Simon, A. C. Peng, A. I. Robles, R. T. Jones, T. Katagiri, P. He, H. Mizukami, L. Charboneau, et al.
Laser Capture Microdissection and Microarray Expression Analysis of Lung Adenocarcinoma Reveals Tobacco Smoking- and Prognosis-related Molecular Profiles
Cancer Res., June 1, 2002; 62(11): 3244 - 3250.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Fujii, T. Dracheva, A. Player, S. Chacko, R. Clifford, R. L. Strausberg, K. Buetow, N. Azumi, W. D. Travis, and J. Jen
A Preliminary Transcriptome Map of Non-Small Cell Lung Cancer
Cancer Res., June 1, 2002; 62(12): 3340 - 3346.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Toyooka, K. O. Toyooka, K. Harada, K. Miyajima, P. Makarla, U. G. Sathyanarayana, J. Yin, F. Sato, N. Shivapurkar, S. J. Meltzer, et al.
Aberrant Methylation of the CDH13 (H-cadherin) Promoter Region in Colorectal Cancers and Adenomas
Cancer Res., June 1, 2002; 62(12): 3382 - 3386.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Sasatomi, S. D. Finkelstein, J. D. Woods, A. Bakker, P. A. Swalsky, J. D. Luketich, H. C. Fernando, and S. A. Yousem
Comparison of Accumulated Allele Loss between Primary Tumor and Lymph Node Metastasis in Stage II Non-small Cell Lung Carcinoma: Implications for the Timing of Lymph Node Metastasis and Prognostic Value
Cancer Res., May 1, 2002; 62(9): 2681 - 2689.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Ji, M. Nishizaki, B. Gao, D. Burbee, M. Kondo, C. Kamibayashi, K. Xu, N. Yen, E. N. Atkinson, B. Fang, et al.
Expression of Several Genes in the Human Chromosome 3p21.3 Homozygous Deletion Region by an Adenovirus Vector Results in Tumor Suppressor Activities in Vitro and in Vivo
Cancer Res., May 1, 2002; 62(9): 2715 - 2720.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Mora, N.-K. V. Cheung, S. Oplanich, L. Chen, and W. L. Gerald
Novel Regions of Allelic Imbalance Identified by Genome-wide Analysis of Neuroblastoma
Cancer Res., March 1, 2002; 62(6): 1761 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Halmos, C. S. Huettner, O. Kocher, K. Ferenczi, D. D. Karp, and D. G. Tenen
Down-Regulation and Antiproliferative Role of C/EBP{alpha} in Lung Cancer
Cancer Res., January 1, 2002; 62(2): 528 - 534.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. L. Xu, L. C. Wu, F. Du, A. Davis, M. Peyton, Y. Tomizawa, A. Maitra, G. Tomlinson, A. F. Gazdar, B. E. Weissman, et al.
Inactivation of Human SRBC, Located within the 11p15.5-p15.4 Tumor Suppressor Region, in Breast and Lung Cancers
Cancer Res., November 1, 2001; 61(21): 7943 - 7949.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Toyooka, K. O. Toyooka, R. Maruyama, A. K. Virmani, L. Girard, K. Miyajima, K. Harada, Y. Ariyoshi, T. Takahashi, K. Sugio, et al.
DNA Methylation Profiles of Lung Tumors
Mol. Cancer Ther., November 1, 2001; 1(1): 61 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Wang, L. Wang, M. D. Callister, J. B. Putnam, L. Mao, and L. Li
Human Rad17 Is Phosphorylated upon DNA Damage and also Overexpressed in Primary Non-Small Cell Lung Cancer Tissues
Cancer Res., October 1, 2001; 61(20): 7417 - 7421.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. O. Toyooka, S. Toyooka, A. K. Virmani, U. G. Sathyanarayana, D. M. Euhus, M. Gilcrease, J. D. Minna, and A. F. Gazdar
Loss of Expression and Aberrant Methylation of the CDH13 (H-Cadherin) Gene in Breast and Lung Carcinomas
Cancer Res., June 1, 2001; 61(11): 4556 - 4560.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. I. Wistuba, M. Tang, A. Maitra, H. Alvarez, P. Troncoso, F. Pimentel, and A. F. Gazdar
Genome-wide Allelotyping Analysis Reveals Multiple Sites of Allelic Loss in Gallbladder Carcinoma
Cancer Res., May 1, 2001; 61(9): 3795 - 3800.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. Zöchbauer-Müller, K. M. Fong, A. K. Virmani, J. Geradts, A. F. Gazdar, and J. D. Minna
Aberrant Promoter Methylation of Multiple Genes in Non-Small Cell Lung Cancers
Cancer Res., January 1, 2001; 61(1): 249 - 255.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. I. Lerman and J. D. Minna
The 630-kb Lung Cancer Homozygous Deletion Region on Human Chromosome 3p21.3: Identification and Evaluation of the Resident Candidate Tumor Suppressor Genes
Cancer Res., November 1, 2000; 60(21): 6116 - 6133.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.